Actively Recruiting

Phase Not Applicable
Age: 50Years - 75Years
All Genders
ID06730074

A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease

Led by Adi Negev-Nahalat Eran · Updated on 2024-12-17

15

Participants Needed

1

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate a new robotic system designed to help people with Parkinson's disease (PD) improve both motor and cognitive functions. The study focuses on a gamified rehabilitation approach that uses robots and music while participants are seated. Researchers will collect both subjective feedback from users and objective measurements of motor and cognitive performance to understand the system's effects. The study will involve 15 individuals with Parkinson's disease, aged 50 to 75, who will each use the robotic system five times, with each session lasting 30 minutes. The intervention includes features like repetitive and goal-oriented practice, varied difficulty levels, rhythmic cues, and social interaction. This is the first socially assistive robotic platform developed specifically for people with PD, and it may become part of clinical rehabilitation tools if successful. Participants will undergo assessments before the first session and after completing all five sessions. These evaluations include cognitive tests like the MoCA and Color Trails Test, motor assessments such as the UPDRS and Box & Blocks Test, and questionnaires on usability, motivation, and satisfaction. Researchers will monitor engagement levels and improvements in motor and cognitive functions over the course of the study, which is expected to continue until August 2025.

CONDITIONS

Brief Title

A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease

Who Can Participate

Age: 50Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signing the informed consent form
  • Men and women aged 50 to 75 years
  • Hebrew speakers
  • Diagnosis of idiopathic Parkinson's disease
  • Hoehn and Yahr stage 3 or below
  • Montreal Cognitive Assessment (MoCA) score of 23 or higher
Not Eligible

You will not qualify if you...

  • Diagnosis of Parkinson's plus syndromes
  • Parkinson's disease patients with unrelated neurological symptoms
  • Orthopedic problems of the upper limbs
  • Recent surgery on the upper limbs
  • Uncorrected vision problems
  • Uncorrected severe hearing loss

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Approximately 2 to 3 weeks

Participants use a gamified robotic rehabilitation system in a sitting position for motor-cognitive exercise. Each participant completes five sessions, each lasting 30 minutes, incorporating principles like repetitive practice and social interaction.

5 sessions (in-person)

Follow-up

Duration - Up to 1 week after the last session

Participants undergo post-intervention assessments to evaluate motor and cognitive improvements as well as system usability and motivation.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Adi Negev

Ofakim, South, Israel

Actively Recruiting

Loading map...

Research Team

D

Dori Katz, Medical Doctor

I

Ilanit Baum Cohen, Msc. OT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

1

Similar Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Stud...

Parkinson Disease

Actively Recruiting

70 locations

Artificial Intelligence-Driven Freezing Of Gait Detection in...

Parkinson Disease, Idiopathic

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here